UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000051293 |
|---|---|
| Receipt number | R000058501 |
| Scientific Title | Investigation of the high-risk person with fatty liver according to metabolic dysfunction-associated fatty liver disease at medical check-ups |
| Date of disclosure of the study information | 2023/08/01 |
| Last modified on | 2023/09/06 14:40:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease at the medical check-ups
Acronym
Investigation of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease
Scientific Title
Investigation of the high-risk person with fatty liver according to metabolic dysfunction-associated fatty liver disease at medical check-ups
Scientific Title:Acronym
Investigation of the high-risk person with fatty liver according to metabolic dysfunction-associated fatty liver disease at medical check-ups
Region
| Japan |
Condition
Condition
Subjects who underwent a medical check-up
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Investigation of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease at the medical check-ups
Basic objectives2
Others
Basic objectives -Others
Extraction of the factors associated with NAFLD or MAFLD
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Investigation of NAFLD and MAFLD and factors associated with these disease
Key secondary outcomes
Association between NAFLD or MAFLD and various diseases including digestive organ disease
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Subjects who underwent a medical check-up
Key exclusion criteria
None
Target sample size
100000
Research contact person
Name of lead principal investigator
| 1st name | Toshiya |
| Middle name | |
| Last name | Okahisa |
Organization
Institute of Biomedical Sciences, Tokushima University Graduate School
Division name
Department of General Medicine and Community Health Science
Zip code
770-8503
Address
3-18-15 Kuramoto-cho, Tokushima city
TEL
088-634-6415
okahisa5505@tokushima-u.ac.jp
Public contact
Name of contact person
| 1st name | Masahiro |
| Middle name | |
| Last name | Sogabe |
Organization
Health Service, Counseling and Accessibility Center, Tokushima University
Division name
Health Service
Zip code
770-8502
Address
1-1 Minamijyosanjima-cho, Tokushima city
TEL
088-656-7289
Homepage URL
sogabe.masahiro@tokushima-u.ac.jp
Sponsor or person
Institute
Shikoku Central Hospital of the Mutual aid Association of Public School teachers
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee of the Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers
Address
2233 Kawanoe-cho, Shikokuchuo city, Ehime 799-0193
Tel
0896-58-3515
soumu@shikoku-ctr-hsp.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 08 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2023 | Year | 06 | Month | 08 | Day |
Date of IRB
| 2023 | Year | 07 | Month | 27 | Day |
Anticipated trial start date
| 2023 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2034 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We investigate about NAFLD and MAFLD. Additionally, we clarify the association between NAFLD or MAFLD and various diseases including digestive system diseases.
Management information
Registered date
| 2023 | Year | 06 | Month | 08 | Day |
Last modified on
| 2023 | Year | 09 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058501
